International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions

被引:8
作者
Reed, Shelby D. [1 ]
Lavezzari, Gabriela [2 ]
机构
[1] Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA
[2] Duke Univ, Robert J Margolis Ctr Hlth Policy, Durham, NC USA
关键词
D O I
10.1016/j.jval.2016.06.004
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:727 / 729
页数:3
相关论文
共 13 条
  • [1] [Anonymous], EXT LED PAT FOC DRUG
  • [2] [Anonymous], 2016, 2016 2017 STRAT PRIO
  • [3] Dong D, 2016, VALUE HEALTH, V19, pxx
  • [4] dosReis S, 2016, VALUE HEALTH, V19, pxx
  • [5] Finkelstein EA, 2016, VALUE HEALTH, V19, pxx
  • [6] Ho M, 2016, VALUE HEALTH, V19, pxx
  • [7] Hollin IL, 2016, VALUE HEALTH, V19, pxx
  • [8] Innovative Medicines Initiative, PROTECT PHARM RES OU
  • [9] Johnson FR, 2016, VALUE HEALTH, V19, pxx
  • [10] Klein AV, 2016, VALUE HEALTH, V19, pxx